Logo image of ALEO2.PA

EO2 (ALEO2.PA) Stock Fundamental Analysis

EPA:ALEO2 - Euronext Paris - Matif - FR0010465534 - Common Stock - Currency: EUR

3.28  0 (0%)

Fundamental Rating

2

Overall ALEO2 gets a fundamental rating of 2 out of 10. We evaluated ALEO2 against 61 industry peers in the Oil, Gas & Consumable Fuels industry. ALEO2 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALEO2 is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALEO2 was profitable.
ALEO2 had a negative operating cash flow in the past year.
In the past 5 years ALEO2 has always been profitable.
ALEO2 had a positive operating cash flow in 4 of the past 5 years.
ALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFALEO2.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

With a Return On Assets value of 1.60%, ALEO2 is not doing good in the industry: 80.33% of the companies in the same industry are doing better.
ALEO2 has a Return On Equity of 3.48%. This is amonst the worse of the industry: ALEO2 underperforms 80.33% of its industry peers.
ALEO2 has a worse Return On Invested Capital (0.74%) than 83.61% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALEO2 is significantly below the industry average of 14.67%.
Industry RankSector Rank
ROA 1.6%
ROE 3.48%
ROIC 0.74%
ROA(3y)4.32%
ROA(5y)3.34%
ROE(3y)9.77%
ROE(5y)7.71%
ROIC(3y)4.43%
ROIC(5y)3.25%
ALEO2.PA Yearly ROA, ROE, ROICALEO2.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

With a Profit Margin value of 2.08%, ALEO2 is not doing good in the industry: 80.33% of the companies in the same industry are doing better.
ALEO2's Profit Margin has declined in the last couple of years.
ALEO2 has a Operating Margin of 1.19%. This is amonst the worse of the industry: ALEO2 underperforms 83.61% of its industry peers.
ALEO2's Operating Margin has declined in the last couple of years.
ALEO2 has a Gross Margin (42.46%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ALEO2 has grown nicely.
Industry RankSector Rank
OM 1.19%
PM (TTM) 2.08%
GM 42.46%
OM growth 3Y-4.51%
OM growth 5Y-16.63%
PM growth 3Y23.02%
PM growth 5Y-5.38%
GM growth 3Y25.04%
GM growth 5Y9.23%
ALEO2.PA Yearly Profit, Operating, Gross MarginsALEO2.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALEO2 is destroying value.
The number of shares outstanding for ALEO2 has been reduced compared to 1 year ago.
The number of shares outstanding for ALEO2 has been reduced compared to 5 years ago.
ALEO2 has a worse debt/assets ratio than last year.
ALEO2.PA Yearly Shares OutstandingALEO2.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ALEO2.PA Yearly Total Debt VS Total AssetsALEO2.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that ALEO2 is in the distress zone and has some risk of bankruptcy.
ALEO2 has a Altman-Z score (1.77) which is comparable to the rest of the industry.
ALEO2 has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
ALEO2's Debt to Equity ratio of 0.50 is in line compared to the rest of the industry. ALEO2 outperforms 45.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z 1.77
ROIC/WACC0.12
WACC6.35%
ALEO2.PA Yearly LT Debt VS Equity VS FCFALEO2.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 2.59 indicates that ALEO2 has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.59, ALEO2 belongs to the best of the industry, outperforming 80.33% of the companies in the same industry.
A Quick Ratio of 1.80 indicates that ALEO2 should not have too much problems paying its short term obligations.
The Quick ratio of ALEO2 (1.80) is better than 70.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 1.8
ALEO2.PA Yearly Current Assets VS Current LiabilitesALEO2.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALEO2 have decreased strongly by -96.09% in the last year.
ALEO2 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.52% yearly.
The Revenue for ALEO2 has decreased by -31.55% in the past year. This is quite bad
ALEO2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.99% yearly.
EPS 1Y (TTM)-96.09%
EPS 3Y35.45%
EPS 5Y0.52%
EPS Q2Q%-58.53%
Revenue 1Y (TTM)-31.55%
Revenue growth 3Y11.24%
Revenue growth 5Y5.99%
Sales Q2Q%-17.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEO2.PA Yearly Revenue VS EstimatesALEO2.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALEO2.PA Yearly EPS VS EstimatesALEO2.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 0.1 0.2 0.3 0.4 0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALEO2 is valuated quite expensively with a Price/Earnings ratio of 46.86.
Based on the Price/Earnings ratio, ALEO2 is valued a bit more expensive than the industry average as 77.05% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.31. ALEO2 is valued rather expensively when compared to this.
Industry RankSector Rank
PE 46.86
Fwd PE N/A
ALEO2.PA Price Earnings VS Forward Price EarningsALEO2.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALEO2 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.95
ALEO2.PA Per share dataALEO2.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)89.32
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALEO2 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EO2

EPA:ALEO2 (6/13/2025, 7:00:00 PM)

3.28

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners28.33%
Ins Owner ChangeN/A
Market Cap7.87M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 46.86
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.42
EV/EBITDA 5.95
EPS(TTM)0.07
EY2.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.82
FCFYN/A
OCF(TTM)-1.1
OCFYN/A
SpS14.2
BVpS8.5
TBVpS7.82
PEG (NY)N/A
PEG (5Y)89.32
Profitability
Industry RankSector Rank
ROA 1.6%
ROE 3.48%
ROCE 1.14%
ROIC 0.74%
ROICexc 0.93%
ROICexgc 0.98%
OM 1.19%
PM (TTM) 2.08%
GM 42.46%
FCFM N/A
ROA(3y)4.32%
ROA(5y)3.34%
ROE(3y)9.77%
ROE(5y)7.71%
ROIC(3y)4.43%
ROIC(5y)3.25%
ROICexc(3y)7.15%
ROICexc(5y)5.22%
ROICexgc(3y)7.62%
ROICexgc(5y)5.52%
ROCE(3y)6.78%
ROCE(5y)4.98%
ROICexcg growth 3Y-0.06%
ROICexcg growth 5Y-15.64%
ROICexc growth 3Y-0.72%
ROICexc growth 5Y-16.61%
OM growth 3Y-4.51%
OM growth 5Y-16.63%
PM growth 3Y23.02%
PM growth 5Y-5.38%
GM growth 3Y25.04%
GM growth 5Y9.23%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA 4.41
Cap/Depr 218.47%
Cap/Sales 12.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 1.8
Altman-Z 1.77
F-Score3
WACC6.35%
ROIC/WACC0.12
Cap/Depr(3y)123.02%
Cap/Depr(5y)99.34%
Cap/Sales(3y)7.35%
Cap/Sales(5y)6.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.09%
EPS 3Y35.45%
EPS 5Y0.52%
EPS Q2Q%-58.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.55%
Revenue growth 3Y11.24%
Revenue growth 5Y5.99%
Sales Q2Q%-17.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.7%
EBIT growth 3Y6.23%
EBIT growth 5Y-11.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-264.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-147.88%
OCF growth 3YN/A
OCF growth 5YN/A